USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Institute for Research in Biomedicine

USPTO PatentsView assignee record - 61 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

RSS updates for this company

The verdict

According to USPTO PatentsView, Institute ranks #5,599 of 49,997 tracked US assignees by granted-patent volume, with 61 patents across 12 technology areas.

#5,599
of 49,997 US assignees by volume
Top 31%
by Innovation Score (42.1/100)
21.1
avg claims per patent
-30%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5599 · Foreign Corporation #5,599 · 61 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 61 grants
  • UPPER-Q #5,599/49,997
  • PHOTO-FINISH Harbin Engineering…
  • CPC-FOCUS C07K · 12 areas
  • INNOV-PAR 42.1/100
  • CLAIMS-DENSE 21.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -30% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Harbin Engineering University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Institute’s 42.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Institute

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Institute's Innovation Score is 42.1/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Institute?

Each dot is one of Institute’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Institute’s own 21.1 claims/patent is ABOVE the 7.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Institute vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 60.961.061.06161.061.061.1 0510152025 Granted patents (volume) Avg claims / patent Harbin Engineering University - 61, 7.07Harbin Engineerin…Infinidat Ltd. - 61, 19.59InfinidatInnovaplant Zierpflanzen GmbH + Co. KG - 61, 1Innovaplant Zierp…Inpria Corporation - 61, 19.28InpriaKolster Holding B.V. - 61, 1Kolster Holding B…Kraft Foods R & D, Inc. - 61, 13.87Kraft Foods R & DKimball International, Inc. - 61, 2.43Kimball Internati…Lesaffre ET Compagnie - 61, 13.75Lesaffre ET Compa…Institute for Research in Biomedicine - 61, 21.08Institute for Res…
Institute vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Institute's grants concentrate

Institute for Research in Biomedicine is a focused PatentsView assignee: 12 CPC subclasses with 98.4% of grants classified under C07K (Peptides). Peak complete grant year is 2016 (9 grants) versus a trough of 1 in 2022. By volume, Institute sits between Harbin Engineering University and Lesaffre ET Compagnie.

Institute's three-year grant acceleration

From 2019–2021 to 2022–2024, Institute for Research in Biomedicine moved from 20 to 9 grants (0.45x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Institute's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Institute holds 61 patents at rank #5,598, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Institute

By rank, the assignees closest to #5,598 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Institute's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Institute, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Institute ranks #138 of 3,615 assignees by patent count in that subclass.

Institute's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 20152016201720182019202020212022202320242025 5
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Institute for Research in Biomedicine patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 8.2%
2016 9 14.8%
2017 8 13.1%
2018 5 8.2%
2019 6 9.8%
2020 6 9.8%
2021 8 13.1%
2022 1 1.6%
2023 7 11.5%
2024 1 1.6%
2025partial year 5 8.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Institute for Research in Biomedicine's patent record in context - here's where to go next.

  • Institute for Research in Biomedicine's lead technology class is C07K (Peptides), 98.4% of its portfolio - see every assignee active in that class. Explore C07K
  • Ranked #5,599 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Institute for Research in Biomedicine against Harbin Engineering University, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.